Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
But with what guarantee? You want my money, my kids' money, thier kids' money, etc to bail out reckless, greedy banks and mortgage lenders?
The least the Fed and Paulsen could do is build in a higher rate of taxation on those institutions that need bailouts, so that once they get back on thier feet, they can re-pay the bailout money with adjustment for inflation.
ADA.TO
adding to my position- one of many juniors that have taken it on the chin lately
I agree 100%. The 8k had me scared until I read the strike price of $1.75. Clearly the Admiral must have liked what he saw.
I take the increase in BOD members from 4 to 6 as a bullish sign as well. Hopefully positive test results will be confirmed very soon, and we can get a better glimpse into LWLG's plan to commercialize their products moving forward. I figure that's why they hired on someone with connections: they have the goods, now they need the delivery service.
Actually, I have to support Supra a bit here.
With start-ups and small companies trying to get their act together, companies that are still evolving from the big idea model to the commercial model, a serious part of DD involves evaluating whether the company achieves its milestones within the time frames that the company itself announces.
And of course if they are late, evaluation has to center on why. Has the necessary information for approval been provided to the peak certifying body? And is the matter out of the company's hands because of bureaucratic delays?
I can and do live with the above scenario (CTGI). But if the delays are the fault of the company, then not probing deeper as to the reasons is IMO nothing short of goofy.
I'm still trying to figure out why these delays have happened with ARSC.
Hi Ken, I was just looking at the Hydrafuelcell.com website, (products link) but the web page was short on technical specifics. Could you please post the HydraSTAX™ specs so that I can get a better idea of exactly what the capabilities are?
TIA
I haven't sold a single share since my initial purchase in '05. This is my one viable iron in the fire, the best shot I have for early retirement. The story here is better than it was in '05, and with the CE mark in the bag, leaning on the FDA becomes more legitimate.
At times like this, it's good to remember the other 3-4 times over the past few years that I didn't sell on the up-spike, only to wonder "what if" as the PPS painfully and methodically re-traced 70%. But the reason I didn't sell then remains just as valid: I don't want to miss out on a boatload by choosing a handful.
Now that 1$ PPS has been breached, I'm actually feeling less frustrated than I did as I watched the slow bleed to this level. I see it like this: with approval comes limitless possibility. Until approval happens, PPS is randomly assigned, unsupportable and easily manipulated.
We have as much business trading at .94 per share as we did at 2.38. Or .04
All this talk of TA and support and Bollinger Bands....as if this is a company with assessable financial metrics, with revenue and contracts, with growth that has a history and therefore can be forecast into the future.
DR's "expectation" of FDA approval in Q2 might have been enough to stave off sub-one dollar PPS, but now that that time has passed, what's to stop a drop to .70?
Lower closing prices now mean that any FDA pop will also result in a lower high when approval day happens.
Persoanlly, I can't wait until we move beyond this purgatory of waiting and expecting, into selling and expanding.
"Does anyone have any thoughts?"
Here goes: this is not a new company, even if the ideas they are commercializing are novel. In it's history, CTGI has never lacked for credible potential: the landfill gas deal with Dupont, LTC and now CO2 scrubbing.
At some point, and I believe it will be this year, CTGI needs to prove that at least one of these ideas can make $$. They don't actually have to make the $$ this year, but they need to demonstrate $$ making-potential beyond the "big idea" step.
FDA, CE mark, a partner who brings $$ to the CO2 party- any of these confirmations would signal to investors that CTGI has actually gone beyond ideas and can be valued as a revenue generating enterprise. Until this happens, we're looking at low volume trading days in a narrow range, with the occasional pop attributable to some pump-newsletter.
Landfill gas was supposed to pave the way for LTC. Ironically, it could easily be the other way around.
DXE DualEx Energy up .095 to .44
Lots of irons in the fire here...
Rocketeer: And any word on Certification? Any indication where the process stands at the current time?
Lowman: Yes, and that's the BEST part of it all! Rocketeer, the ten minute minds think in ten minute terms. They will forever be stuck in their ten minute worlds, while others (like I) will be basking on islands we own all to ourselves.
So please help me decode your response. You say "yes". Does that mean you asked specifically about Certification? If so, could you please share the response you were given? I'm confused....surely management didn't come up with the "10 minute minds" reply?
I'm only asking what I think is not an unimportant question. If you didn't broach the subject, a simple, "didn't ask 'em about that one" would suffice.
I am very aware of your feelings for ARSC and I'm not in any way attempting to pass judgement on your opinion.
TIA
And any word on Certification? Any indication where the process stands at the current time?
DXE breaks out to a new high on big volume after a long time consolidating in the mid .20s
Don also expected the IPO of LTC to be in Nov 2006, or something like that. And he said FDA submission for LTC was going to happen in Q1 2007.
So while hopeful of FDA news soon, owning CTUM is a lesson in patience.
I like the idea of a new FDA approval announcement date pool. I'm in for:
Sept 9, 2008 9:30 am
50k a year.....should cover pizza and soft drinks....
Some good news on the testing results I was asking about. It looks like we're 2/3 of the way to commercialization, with the final 1/3 tipped to be in the bag.
I can't wait until this company gets some recognition!
http://biz.yahoo.com/prnews/080527/netu037.html?.v=56
Does anyone have a date for the UZona independent assessment of the protype? We've been taking some hits lately and I too hope it's not related to anything other than ennui.
Does anyone have a date for the UZona independent assessment of the protype? We've been taking some hits lately and I too hope it's not related to anything other than ennui.
is currently working towards... ie, another great idea with no cash to back it.
A year ago I dumped this poodle, right after the PR that stated they were working toward a bio-reactor in Erie in the Spring of 2008. There hasn't even been pizza money coming into this company since well before Brett rode to the rescue and that hasn't changed a bit since he started running the show....not even the mythical, elusive government grant....
The cavalry's been a long time comin' pardner.
1. It's easy enough to see if DR sold shares. Check the SEC website for form 4s.
2.I'm not the only one who posted that CTGI could easily trade under a buck without FDA approval. Right now, CTGI is a a company of great ideas. (well really one great idea that we know about). Idea-based outfits have a much more abstract and flexible value than outfits with active balance sheets. The posters here who thought that CTGI was more fairly valued at $2.30+ per share had nothing more than their strong beliefs and desires to support that idea.
3. My sell order is in at $12.50 a share. Since my initial purchase in 2005, I've had many opportunities to look back and think, "what if I had sold and bought back 2 months later?" I trade some companies, but not this one. This is scene 3 in a 20 scene blockbuster! I want to see how it's going to end.
4. I hear you on the 200k for the greased pump. But I have to cut DR some slack here as well. Looking back at all the PR activity surrounding the run to $2.39, I gotta' think that DR anticipated FDA approval to coincide with the paid pump. FDA approval at this particular time would have fetched a very handsome price for the LTC IPO. It didn't work out. That said, I'm sure DR has other ideas in the pipeline to fully capitalize on the FDA approval announcement, so that the IPO is priced as high as possible. The way I see it, if 200k can almost triple your PPS once, it can certainly be done again, especially if you have the FDA stamp of approval.
5. Nothing negative has transpired with this company. The PRs have been encouraging and show a company moving forward with their plan, controlling the factors they can control while they await the resolution of those factors that aren't in their hands.
Just remember that it was one year ago when we were waiting for FDA submission. The original date set by DR was March '07, which came and went. And the share price slowly and consistently slid back down.
Q2 is 1/2 in the books. "Expect" FDA approval within the next 6 weeks.
I concur whole heartedly. Unfortunately, the horse might have gotten ahead of the cart with LTC: I'm convinced, if only because it makes business sense, that DR started lining up production and professional salaries because he felt that FDA approval was imminent. Why else would you take on that level of commitment with no cash in-flow on the horizon? And the wording in the previous 10K, "expect," indicates a perturbed tone that the proceedings have taken this long.
I grant you that the PRs aren't very compelling and exciting. But let's get serious: any small amount of DD will show not only that the CO2 seperater didn't happen as forecast, but that the company submitted an application for FDA approval in Aug. 07...and of course, it hasn't yet happened. How much excitement and cash can you expect to generate under these circumstances? The OTC especially is packed with billion dollar ideas, the vast majority of which will never survive. This is why I emphasized in a previous post the HUGE amount riding on FDA approval.
Maybe it would be better to issue shares now, at the current PPS because if approval is delayed beyond Q2, we may, as you point out, trade to the right of the decimal point again.
Clearly we're all frustrated by the waiting game. But I think that's our destiny for the near term. Well written or not, there's been very little movement after the last few PRs about Ukrainian Engineers and the Vet subsidiaries, etc. I'm actually very surprised that the PPS has held up this well. Low volume days in a 10 cent range look pretty good to me about now. There's only one PR I want to read when I check my computer, but I'll know it's there before I read it because I check the ticker for CTGI first!
"if the CEO and his team are as sharp as stated (by several folks here) then this should have already been done."
A share price of $1.40 a pop for a product that hasn't been endorsed by the ESSENTIAL watchdog government agency is a pretty damn good indicator of a razor-sharp CEO and his team IMHO.
Revenue, revenue, revenue. That's what the DuPont deal was all about way back when, but because it didn't come to pass, dilution may well be in the cards for us. I'm not too fearful of dilution here for a number of reasons:
1. DR has shown that he is very frugal with the printing press over the years. There's no reason to think that practice won't continue.
2. I agree with Training Surgeons that the diffeence-maker for this technology and this company is proving up the claim of suturing organs with no necrosis. If LTC can power ahead with this technology, the amounts discussed by us on this board won't mean much.
3. Big names do cost $$. But our big names are willing to defer their payday until the technology that they independently assessed begins to reap rewards. They know much, much more than we do. If they like it, I love it.
The best PR for this company if FDA approval.
An inflated stock price has been achievable for CTUM in the past. Maintaining that price after the weeks pass with no news of revenues, approvals, etc IS the problem.
I'm in accord with the group that sees FDA approval as the biggest, oiliest pump the company can wield. As a long term holder, I don't want a single dime to be spent pumping the PPS until approval happens.
DXE on a surge lately. Lots of possibilities this year with the drill bit
My thought is that the market in the USA would be easier to capitalize on, hence the desire for the FDA approval to come through. The company's offices are in barbie doll central- LA is proof that vanity is a stronger economic force than recession or inflation, and the revenue from the cosmetic subsidiary alone would ensure a nice, high price for the IPO.
If the IPO is based on EU projections, at this point I doubt it would fetch as high a price. I'm sure that Frank will do everything possible to alert the EU market (and the world) about LTC, but there's no doubt that capitalizing on the US market would make the EU a much easier nut to crack.
Could/would the company move forward in the EU without FDA approval (once the handset is approved)? Of course they would. What other choice would they have? But the money needed to penetrate the EU market as LTC's initial revenue stream makes that option much less attractive.
Even greater is that someone or some institution was willing to buy those shares for better than .17
Up from here.
Here it is, from the last 10K:
Total Operating Revenues
We did not recognize any revenue in 2007 or in 2006. We do not expect to begin generating any revenues until such time as we obtain FDA approval for one of our products and commence manufacturing and distribution operations with respect to any such FDA approved product
Maybe DR has better connections in LA than in Europe and that's why he's waiting for the FDA....hard to say exactly, but if Europe was a true priority, I doubt they'd be explicitly stating not to expect revenue until FDA approval.
The original plan was to build LTC from CO2 seperator $$. It didn't happen.
DR has done amazingly well to line up Empire and Frank and push LTC ahead without the $$, so I don't begrudge him the 10 years: it was never going to be a smooth and easy road.
That said, none other than DR himself has stressed the importance of FDA approval. The last 10K made it clear that LTC wasn't being pursued in Europe, in spite of the strong and repeated wishes often touted on this board. LTC will move ahead when FDA approval occurs, which I sincerely hope will be this Q as DR "expects".
IMO, the recent presentations in the Czech Republic and the upcoming event in Florida were meant to act as sales pitches post-FDA approval. Rolling out a technique that can't be used yet isn't as effective as introducing the medical community to fully endorsed and sanctioned technique. My sense is that DR and Frank felt that they had fully complied with what the FDA wanted to see, and that they're becoming impatient with this prolonged delay.
There's a LOT at stake here, let's not kid ourselves: the investment world is packed with great ideas. Few progress to commercial entities. Fewer still become "disruptive" technologies. I'm a believer that FDA approval will happen, (but it's easy to be a believer at a basis price of .041). I don't want to consider the alternative yet, but as time goes by, I can certainly appreciate why investors would be cautious. After all, my original purchase was predicated on the news of gas sales to Dupont! (lol)
Better yet, a deal in China for spot ore prices. Lots of good news potential ahead. 82 million! Love to see those ANZ shares churn through!
The ANZ holding is a bit of an issue as Aussie rules limit the % that an individual bank can hold of any given company. ANZ "inherited" their shares. I think a lot of recent selling has been those shares churning through the market. The volumes have been very high lately, so hopefully the worst is over.
Thanks for that clip. I think this technology is so far removed from what people can imagine....I wonder how long until the U Zona tests are complete?
ADY.AX, ADMRF.PK
Here's a link to a very insightful and candid Q&A with the Phillip Thomas, Executive Director of Admiralty, dated April 11.
http://www.ady.com.au/uploads/news/6974ce5ac660610b44d9b9fed0ff9548.pdf
The fallout/shorting following the Opes Prime debacle has created an amazing buying opportunity at its current PPS of around .17 a share. The bottom seems to be in and there's lots of fantastic news on the near-term horizon.
Averaging down on my .22 position. I can't find another company with as many irons in the fire priced so cheaply. And Aussie companies are under a much more intense microscope from the general public and regulators.
The one hound that needs to be released is the FDA hound. I suspect that CSMG thought they would have FDA approval in the bag by the time of this conference.
Can you post the highlights of the report?
TIA
Ah, the annual fallback. Last year we rose on anticipation of FDA submission....then it didn't happen in Q1 and we drifted downward. Previously, we rose in March on Dupont news and again, drifted down when the news didn't translate into revenue.
We all know the story this year. but let's face it: we are a publically traded company. PRs and newsletters don't prop up share prices for vey long. What we need today is what we needed 1 and 2 years ago: $$$$$$$$ coming in from the big ideas.
DR said expect FDA approval in Q2. That's EXACTLY what I expect. And then I expect this company to move ahead like any other company in its sector, with revenue, expansion and earnings. I liked it a lot at .04 and I love it now.
If the LTC rollout happens as planned, 1-2 bucks will be a distant memory in 1-2 years
Lowman, you wrote:
"CSMG's CO2 technology function just fine where it is currently being used (in Ukraine and anywhere else Sumy-Frunze has placed it)."
Back when the Dupont contract had us all excited but the landfill gas wasn't happening (for whatever reason), I emailed DR to ask specifically if and where the CO2 seperator was currently functioning and what the production levels were. I never heard back.
Your post suggests that you know something I've been trying to confirm for some time. Do you have solid information/links to support the above claim?
TIA
And still it's basically under the radar. IMO, not even the traders and manipulators are onto to this company yet.
I'll hold my .78 shares and wait for the prototype to blow people away.
Agreed. This is strong langauge for a DR PR.
Clearly at the time of submission, there were a few FDA hoops left to jump through, and at 3-6 weeks a hoop, it's no wonder that approval time has been pushed back so much farther than we wanted.
AUY Leaps are looking more farly valued now than they have in some time. The stock PPS was punished after reporting earnings and revenue much lower than analyst's expectations.
Given that AUY revised estimates well before the latest earnings announcement, a more likely story is that the PPS is being manipulated today for bigger gains tomorrow, when gold and copper start the next move upwards.
When you submit a device for FDA approval, anything BUT FDA approval can't be considered good news. That said, I'm still VERY confident that FDA approval will come to CTGI. The team that submitted the application is just too good to have it turn out any other way.
With regard to EU revenue, my understanding is that CTGI currently has approval for the generator. They are still waiting approval for the handsets. I believe both components are necessary for the procedure.
As for the delay in FDA approval somehow being good for CTGI.....this is hard for me to see. I only have to ask myself what if CTUM gained approval in October of 2007? Today the PR's would potentially be about revenue and training, and the share price would reflect the potential that these PRs portend.
Waiting is frustrating for all uf us, but unlike us, DR is still busy while he waits. Beyond approval, what I hope to see is a blitz of PRs in the weeks following approval about the rapid expansion of LTC.
IMHO, any price north of $1 a share is a bonus in this pre-approval time. I've waited 3 years, never really tempted to sell any of my 100k shares that Cornell made possible at .04 a pop. My current sell order is at $12.50.